- Home
- YHGJ vs CLGN Comparison
YHGJ vs CLGN Comparison
Compare YHGJ & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- CLGN
- Stock Information
- Founded
- YHGJ 1975
- CLGN 2004
- Country
- YHGJ United States
- CLGN Israel
- Employees
- YHGJ N/A
- CLGN N/A
- Industry
- YHGJ Specialty Chemicals
- CLGN Industrial Specialties
- Sector
- YHGJ Industrials
- CLGN Health Care
- Exchange
- YHGJ Nasdaq
- CLGN Nasdaq
- Market Cap
- YHGJ 22.5M
- CLGN 19.1M
- IPO Year
- YHGJ 1997
- CLGN N/A
- Fundamental
- Price
- YHGJ $0.73
- CLGN N/A
- Analyst Decision
- YHGJ
- CLGN Strong Buy
- Analyst Count
- YHGJ 0
- CLGN 2
- Target Price
- YHGJ N/A
- CLGN $11.50
- AVG Volume (30 Days)
- YHGJ 6.0K
- CLGN 103.1K
- Earning Date
- YHGJ 05-20-2025
- CLGN 08-19-2025
- Dividend Yield
- YHGJ N/A
- CLGN N/A
- EPS Growth
- YHGJ N/A
- CLGN N/A
- EPS
- YHGJ N/A
- CLGN N/A
- Revenue
- YHGJ $17,861,000.00
- CLGN $2,472,000.00
- Revenue This Year
- YHGJ N/A
- CLGN $2,177.67
- Revenue Next Year
- YHGJ N/A
- CLGN $56.52
- P/E Ratio
- YHGJ N/A
- CLGN N/A
- Revenue Growth
- YHGJ 1.21
- CLGN N/A
- 52 Week Low
- YHGJ $0.43
- CLGN $1.31
- 52 Week High
- YHGJ $1.37
- CLGN $5.48
- Technical
- Relative Strength Index (RSI)
- YHGJ 47.03
- CLGN 41.28
- Support Level
- YHGJ $0.71
- CLGN $1.31
- Resistance Level
- YHGJ $0.85
- CLGN $1.54
- Average True Range (ATR)
- YHGJ 0.07
- CLGN 0.14
- MACD
- YHGJ 0.01
- CLGN -0.00
- Stochastic Oscillator
- YHGJ 41.20
- CLGN 14.21
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.